Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03277066 · ClinicalTrials.gov registry record · Phase 2
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
A Phase 2 study of Osteoarthritis of the Knee, sponsored by Noven Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 289
- Enrollment target
- 1
- Study location
NCT03277066: Completed Phase 2 study of Osteoarthritis of the Knee, sponsored by Noven Pharmaceuticals.
NCT03277066 is a Phase 2 study of Osteoarthritis of the Knee that has completed, run by Noven Pharmaceuticals. The registered enrollment target is 289 participants, above the 195-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03277066, a Phase 2 study of Osteoarthritis of the Knee, has completed, sponsored by Noven Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 289 participants
- Enrollment target
- 1
- Study location
Study Summary
A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) of the Knee
Primary Outcome
To evaluate efficacy of HP-5000 Active Topical Patch 1 and HP-5000 Active Topical Patch 2 compared with placebo for the treatment of Osteoarthritis of the knee as evaluated by change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score from baseline to week 4. WOMAC pain score is a scale that evaluate five items including walking, stair climbing, nocturnal, rest and weight bearing. Each item is rated on a scale of 0 to 4, with 0 being no difficulty and 4 being ext
Conditions Studied
Interventions
- DRUG Placebo patch
- DRUG Diclofenac Sodium Active Topical Patch 1
- DRUG Diclofenac Sodium Active Topical Patch 2
Study Locations (1)
New Jersey
- Noven Pharmaceuticals, Inc. - Jersey City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2019-09-25 |
| Phase | Phase 2 |
What the finished NCT03277066 record still lists
NCT03277066 is an interventional study that assigns participants to a tested intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap, above the 195-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (48% higher).
The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 3 interventions - of which Placebo patch is the first listed.
NCT03277066 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03277066 about?
NCT03277066 is a clinical study titled "A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis". A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) of the Knee
What is the current status of trial NCT03277066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 289 participants. The study started on 2017-09-07. Estimated completion is 2019-09-25.
What conditions does trial NCT03277066 study?
This clinical trial studies the following conditions: Osteoarthritis of the Knee.
What interventions are being tested in trial NCT03277066?
The interventions under investigation include: Placebo patch (DRUG), Diclofenac Sodium Active Topical Patch 1 (DRUG), Diclofenac Sodium Active Topical Patch 2 (DRUG).
Who is sponsoring clinical trial NCT03277066?
This trial is sponsored by Noven Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03277066 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03277066's enrollment target sits among peer trials
289 5th of 16 higher than 12 of 16 other Osteoarthritis of the Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis of the Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee
COMPLETED · Phase 2
-
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
COMPLETED · Phase 2
-
Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee
COMPLETED · Phase 2
-
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
COMPLETED · Phase 2
-
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI